The Enzymes • 2020.10.14
Lukarska M., Palencia A.
- Bacterial mechanisms, New antibiotics and alternatives
- International
- Inhibitors of the editing site of AARSs, Inhibitors of the synthetic site of AARSs, Natural products as inhibitors of AARSs, Protein synthesis inhibitors, Selective inhibitors, Structure-based drug design, Therapeutic targets in infectious diseases
Antibiotics • 2021.03.04
Ngassam Tchamba C., Duprez J.N, Lucas P., et al.
ISME J • 2021.03.10
Wang Y., Lu J., Zhang S. et al.
PNAS • 2021.03.23
Mulligan V.K, Workman S., Sun T.
Front. Microbiol. • 2021.01.26
Kumar M., Kumar Sarma D., Shubham S., et al.
- Antibiotic stewardship, New antibiotics and alternatives
- International
- Alternative therapies, Antimicrobial Peptides, CRISPR-Cas, Fecal Microbiota Transplant, Hemofiltration Devices, Immunotherapeutic, Nanoantibiotics, One Health, Phage Therapies, Postbiotics, Probiotics, Quorum-Sensing Inhibitors, Synbiotics
Microb Genom. • 2019.09.01
Branger C., Ledda A., Billard-Pomares T., et al.
Lancet Infect Dis • 2019.09.25
Kollef M.H., Nová?ek M., Kivistik Ü., et al.
- Clinical trial
- International
- Ceftolozane-tazobactam, Clinical trial, Drug therapy, Meropenem, Nosocomial Pneumonia
Lancet Infect Dis • 2019.10.03
Chang J., Xu S., Zhu S., et al.
Lancet • 2019.06.22
Ross J.D.C., Brittain C., Cole M., Dewsnap C., Harding J., Hepburn T., Jackson L., Keogh M., Lawrence T., Montgomery A.A., Roberts T.E., Sprange K., Tan W., Thandi S., White J., Wilson J., Duley L., G-ToG trial team
- Clinical trial
- International
- Azithromycin, Ceftriaxone, Clinical trial, Gentamicins, Gonorrhea